PFE vs REGN
Pfizer, Inc. Common Stock · Regeneron Pharmaceuticals, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | PFE | REGN |
|---|---|---|
| Price | $27.93 | $803.90 |
| Market Cap | $159.19B | $75.90B |
| P/E | 20.49 | 16.85 |
| P/B | 1.87 | 2.39 |
| P/S | 2.54 | 5.29 |
| ROE | 9.1% | 14.2% |
| Net Margin | 12.4% | 31.4% |
| Gross Margin | — | — |
| Revenue Growth | -1.6% | 1.0% |
| Dividend Yield | 6.16% | — |
| EPS | $1.36 | $47.72 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.